The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis (Q44403155)

2 December 2017

title

The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis (English)

1 reference

2 December 2017

1 reference

Francisco Garcia Soriano

1 reference

2 December 2017

1 reference

2 December 2017

Csaba Szabó

1 reference

2 December 2017

Jon Mabley

1 reference

2 December 2017

György Haskó

1 reference

2 December 2017

Anita Marton

1 reference

2 December 2017

Rebecca Wallace

1 reference

2 December 2017

Andrew Salzman

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

European Journal of Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

466

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

323-329

1 reference

Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: involvement of A3 adenosine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Adenosine, an endogenous anti-inflammatory agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Experimental models of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Nicotine reduces the incidence of type I diabetes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Pharmacologic modulation of acute ocular inflammation. I. Adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Antiserum to tumor necrosis factor and failure to prevent murine colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Chemokines and T lymphocytes: more than an attraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901570-X

10.1016/S0014-2999(03)01570-X

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference